This launch is expected to broaden treatment options for patients affected by peripheral artery disease (PAD).

Johnson & Johnson MedTech ‘s Shockwave Medical announced today that it launched its Javelin peripheral IVL catheter in Europe ...

SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

SANTA CLARA, Calif., Nov. 07, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely ...

Study Seeks to Confirm Benefits of Shockwave’s Coronary IVL in Females Who Historically Have Suffered Less Favorable Clinical Outcomes than Male Patients with Traditional Therapies “When it comes to ...

Johnson & Johnson MedTech’s Shockwave Medical has launched its Javelin Peripheral IVL Catheter in the US for peripheral artery disease (PAD). This new intravascular lithotripsy (IVL) platform is ...

SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular ...

Johnson & Johnson has announced the European launch of its Shockwave Javelin Peripheral IVL Catheter, a novel intravascular ...

Shockwave Medical (NASDAQ:SWAV) said its L 6 Peripheral IVL Catheter was now commercially available in the U.S. following clearance by the U.S. Food and Drug Administration (FDA). The device helps to ...